Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network
Academic Article
Overview
MeSH Major
Biomarkers, Tumor
Lymphoma, T-Cell
Receptor Protein-Tyrosine Kinases
Referral and Consultation
Secondary Care
abstract
In a large cohort of patients with TCL who were referred to National Comprehensive Cancer Network centers, the likelihood of a concordant final diagnosis at a referring institution was low. As current and future therapies target TCL subsets, these data suggest that patients with suspected TCLs would benefit from evaluation by an expert hematopathologist.
